ID.1
Item
pathologically proven non-small cell lung cancer with evidence of distant metastases/malignant pleural effusion
boolean
C0007131 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
ID.2
Item
measurable disease on imaging studies in 2 dimensions
boolean
C1513041 (UMLS CUI [1])
ID.3
Item
no previous therapy with either paclitaxel or vinorelbine, or any chemotherapy for the past five years
boolean
C0144576 (UMLS CUI [1,1])
C0078257 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
ID.4
Item
patients who have had a previous resection for their lung cancer and present with recurrent disease will be eligible
boolean
C0728940 (UMLS CUI [1,1])
C0684249 (UMLS CUI [1,2])
ID.5
Item
patients with other prior malignancies will be included, provided they have been disease-free for at least five years
boolean
C0006826 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0242793 (UMLS CUI [1,3])
ID.6
Item
patients with adequately treated basal cell or squamous cell carcinoma of the skin, adequately treated carcinoma in-situ of the cervix and hormone sensitive prostate cancer will be eligible
boolean
C0007118 (UMLS CUI [1,1])
C0851140 (UMLS CUI [1,2])
C4302896 (UMLS CUI [1,3])
ID.7
Item
karnofsky score >= 70 (eastern cooperative oncology group [ecog] 0-2)
boolean
C0206065 (UMLS CUI [1,1])
C1520224 (UMLS CUI [1,2])
ID.8
Item
white blood cell (wbc) count >= 3,500/mm^3, or
boolean
C0023508 (UMLS CUI [1])
ID.9
Item
absolute neutrophil count (anc) >= 1,500/ul
boolean
C0948762 (UMLS CUI [1])
ID.10
Item
platelet count >= 100,000/mm^3
boolean
C0032181 (UMLS CUI [1])
ID.11
Item
serum creatinine less than 1.5 times the upper limits of normal
boolean
C0600061 (UMLS CUI [1])
ID.12
Item
serum aspartate aminotransferase (ast) and alanine aminotransferase (alt) less than 1.5 times the upper limits of normal
boolean
C0004002 (UMLS CUI [1,1])
C0001899 (UMLS CUI [1,2])
ID.13
Item
serum alkaline phosphatase less than 2.5 times the upper limits of normal
boolean
C0036776 (UMLS CUI [1])
ID.14
Item
no active serious infections or other condition precluding chemotherapy
boolean
C3714514 (UMLS CUI [1])
ID.15
Item
non-pregnant and non-nursing
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.16
Item
men and women of reproductive potential may not participate unless they have agreed to use an effective contraceptive method while on the study
boolean
C0009862 (UMLS CUI [1])
ID.17
Item
able to give informed consent
boolean
C0021430 (UMLS CUI [1])
ID.18
Item
able to return for treatment and follow-up as specified in the protocol
boolean
C3274571 (UMLS CUI [1])
ID.19
Item
known hypersensitivity to any component of vinorelbine or paclitaxel or other required drugs in the study
boolean
C0020517 (UMLS CUI [1,1])
C0078257 (UMLS CUI [1,2])
C0144576 (UMLS CUI [1,3])
ID.20
Item
any comorbidity or condition which, in the opinion of the investigator, may interfere with the assessments and procedures of this protocol
boolean
C0009488 (UMLS CUI [1])
ID.21
Item
inability to fulfill the requirements of the protocol
boolean
C1321605 (UMLS CUI [1])